Reference:
1. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW,
et al. Down syndrome. Nature Reviews Disease Primers. 2020;6(1):1-20.
2. De Toma I, Dierssen M. Network analysis of Down syndrome and
SARS-CoV-2 identifies risk and protective factors for COVID-19.
Scientific Reports. 2021;11(1):1-12.
3. Espinosa JM. Down syndrome and COVID-19: a perfect storm? Cell
Reports Medicine. 2020;1(2):100019.
4. Hüls A, Costa AC, Dierssen M, Baksh RA, Bargagna S, Baumer NT, et al.
An international survey on the impact of COVID-19 in individuals with
Down syndrome. 2020.
5. Carsetti R, Valentini D, Marcellini V, Scarsella M, Marasco E,
Giustini F, et al. Reduced numbers of switched memory B cells with high
terminal differentiation potential in Down syndrome. European journal of
immunology. 2015;45(3):903-14.
6. Prayle AP, Vyas HG. Respiratory Complications of Down Syndrome.
Kendig’s Disorders of the Respiratory Tract in Children. 2019:992-1006.
e2.
7. Clift AK, Coupland CA, Keogh RH, Hemingway H, Hippisley-Cox J.
COVID-19 mortality risk in Down syndrome: results from a cohort study of
8 million adults. Annals of internal medicine. 2021;174(4):572-6.
8. De Cauwer H, Spaepen A. Are patients with Down syndrome vulnerable to
life-threatening COVID-19? Acta Neurologica Belgica. 2021;121(3):685-7.
9. Wadman M. People with Down syndrome face high risk from coronavirus.
American Association for the Advancement of Science; 2020.
10. De Weerd NA, Nguyen T. The interferons and their
receptors—distribution and regulation. Immunology and cell biology.
2012;90(5):483-91.
11. Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, et
al. Mass cytometry reveals global immune remodeling with multi-lineage
hypersensitivity to type I interferon in Down syndrome. Cell reports.
2019;29(7):1893-908. e4.
12. Uppal H, Chandran S, Potluri R. Risk factors for mortality in D own
syndrome. Journal of Intellectual Disability Research.
2015;59(9):873-81.
13. Lambert K, Moo KG, Arnett A, Goel G, Hu A, Flynn KJ, et al. Deep
immune phenotyping reveals similarities between aging, Down syndrome,
and autoimmunity. Science translational medicine. 2022;14(627):eabi4888.
14. Kishimoto T, Kang S. IL-6 Revisited: From Rheumatoid Arthritis to
CAR T Cell Therapy and COVID-19. Annual Review of Immunology. 2022;40.
15. Courtenay K. Covid-19: challenges for people with intellectual
disability. BMJ. 2020;369.
16. Dierssen M. Down syndrome: the brain in trisomic mode. Nature
Reviews Neuroscience. 2012;13(12):844-58.
17. Ahmmad MR, Islam MN. Impact of Disability on Quality of life of
urban disabled people in Bangladesh. International Journal of u-and
e-Service, Science and Technology. 2014;7(4):227-38.
18. Perera B, Laugharne R, Henley W, Zabel A, Lamb K, Branford D, et al.
COVID-19 deaths in people with intellectual disability in the UK and
Ireland: descriptive study. BJPsych open. 2020;6(6).
19. Amin MA, Nahin S, Dola TA, Afrin S, Hawlader MDH. Retinal hemorrhage
of late post‐COVID‐19 and post‐vaccine‐related pathogenic mechanisms: A
new challenge for ophthalmologist in COVID era. Clinical Case Reports.
2022;10(2):e05471.
20. Shields N. Physiotherapy management of Down syndrome. Journal of
physiotherapy. 2021;67(4):243-51.
21. Vazquez-Hernández PI, Cárdenas-Conejo A, Catalán-Ruiz MA,
Navar-Gallegos K, Zenteno-Salazar E, Rafael-Parra-Bravo J, et al.
Multiple Organ Failure Associated with SARS-CoV-2 Infection in a Child
with Down Syndrome: Is Trisomy 21 Associated with an Unfavourable
Clinical Course? Case Reports in Pediatrics. 2021;2021.
22. Evangelho VGO, Bello ML, Castro HC, Amorim MR. Down syndrome: the
aggravation of COVID-19 may be partially justified by the expression of
TMPRSS2. Neurological Sciences. 2022;43(2):789-90.
23. Hüls A, Costa AC, Dierssen M, Baksh RA, Bargagna S, Baumer NT, et
al. Medical vulnerability of individuals with Down syndrome to severe
COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C
survey. EClinicalMedicine. 2021;33:100769.
24. Pérez-Padilla R, Fernández R, García-Sancho C, Franco-Marina F,
Aburto O, López-Gatell H, et al. Pandemic (H1N1) 2009 virus and Down
syndrome patients. Emerging infectious diseases. 2010;16(8):1312.
25. Malle L, Gao C, Hur C, Truong HQ, Bouvier NM, Percha B, et al.
Individuals with Down syndrome hospitalized with COVID-19 have more
severe disease. Genetics in Medicine. 2021;23(3):576-80.
26. Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors
associated with in-hospital mortality in a US national sample of
patients with COVID-19. JAMA network open. 2020;3(12):e2029058-e.
27. Xie Y, Bowe B, Maddukuri G, Al-Aly Z. Comparative evaluation of
clinical manifestations and risk of death in patients admitted to
hospital with covid-19 and seasonal influenza: cohort study. Bmj.
2020;371.
28. Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner
K, et al. Down syndrome and Alzheimer’s disease: Common pathways, common
goals. Alzheimer’s & Dementia. 2015;11(6):700-9.